Tilray Brands, Inc. Payments to Acquire Marketable Securities
Tilray Brands, Inc. (TLRY) reported Payments to Acquire Marketable Securities of $45.44 million for the 3-month period ending 2023-08-31, per its 10-Q filed 2024-10-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-10-10
- Tilray Brands, Inc. payments to acquire marketable securities for the quarter ending 2023-08-31 was $45.44M.
- Tilray Brands, Inc. payments to acquire marketable securities for the quarter ending 2023-05-31 was -$1.29M.
- Tilray Brands, Inc. payments to acquire marketable securities for the quarter ending 2023-02-28 was $0.00.
- Tilray Brands, Inc. payments to acquire marketable securities for the quarter ending 2022-11-30 was $243.19M.
- Tilray Brands, Inc. payments to acquire marketable securities for fiscal 2023 was $241.90M.
- Tilray Brands, Inc. payments to acquire marketable securities for fiscal 2022 was $0.00.
- Tilray Brands, Inc. payments to acquire marketable securities for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2023-08-31 | $45.44M 10-Q · filed 2024-10-10 | $44.15M derived: sum of 2 quarters · filed 2024-10-10 | $44.15M derived: sum of 3 quarters · filed 2024-10-10 | $287.33M derived: sum of 4 quarters · filed 2024-10-10 |
| 2023-05-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$1.29M derived: sum of 2 quarters · filed 2023-07-26 | $241.90M derived: sum of 3 quarters · filed 2023-07-26 | $241.90M 10-K · filed 2023-07-26 |
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $243.19M derived: sum of 2 quarters · filed 2023-04-10 | $243.19M 10-Q · filed 2023-04-10 | $243.19M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $243.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $243.19M 10-Q · filed 2023-01-09 | $243.19M derived: sum of 3 quarters · filed 2024-10-10 | $243.19M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $0.00 10-Q · filed 2024-10-10 | $0.00 derived: sum of 2 quarters · filed 2024-10-10 | $0.00 derived: sum of 3 quarters · filed 2024-10-10 | |
| 2022-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $0.00 derived: sum of 2 quarters · filed 2023-07-26 | $0.00 10-K · filed 2023-07-26 | |
| 2022-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $0.00 10-Q · filed 2023-04-10 | ||
| 2021-11-30 | $0.00 10-Q · filed 2023-01-09 | |||
| 2021-05-31 | $0.00 10-K · filed 2023-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |